Skip to main content
. 2016 Apr 3;2016:2782786. doi: 10.1155/2016/2782786

Table 3.

Differences in maternal characteristics between newborn-monotherapy dyads and newborn-triple therapy dyads.

Maternal characteristic Newborn-monotherapy dyads
Mean (SE) or n (%)
Newborn-triple therapy dyads
Mean (SE) or n (%)
p value
Age (years) 32 (0.7) 28 (1) <0.01
Country of origin
 African 49 (66%) 11 (37%) <0.01
 Canadian 14 (19%) 18 (60%)
 Other 11 (15%) 1 (3%)
Number of prenatal visits 8 (0.5) 4 (0.6) <0.01
Final HIV status
 Positive 70 (83%) 16 (43%) <0.01
 Negative 14 (17%) 21 (57%)
Viral load of those who are HIV-positive
 <50 copies/mL 59 (87%) 2 (15%) <0.01
 50–1000 copies/mL 9 (13%) 6 (46%)
 >1000 copies/mL 0 (0%) 5 (38%)
Partner involved 50 (62%) 17 (47%) NS
HIV status of father of newborn
 Positive 22 (59%) 4 (29%) NS
 Negative 15 (41%) 10 (71%)
Substance use 17 (21%) 25 (69%) <0.01
Smoker 14 (17%) 20 (67%) <0.01
Living situation
 Own home 76 (89%) 21 (57%) <0.01
 Homeless or living in shelter 9 (11%) 16 (43%)
Health insurance (OHIP) 68 (80%) 29 (78%) NS
Social work referral 51 (60%) 33 (89%) <0.01
Lost custody of previous children 8 (16%) 17 (68%) <0.01
Sex work 3 (4%) 12 (34%) <0.01
Employed 29 (41%) 4 (12%) <0.01
Educated 36 (90%) 8 (47%) <0.01
AZT intrapartum 70 (82%) 17 (47%) <0.01

Continuous variable, reported in mean (SE).